Does adjuvant therapy for high-risk melanoma with either immunotherapy or targeted therapy affect therapeutic choices at relapse?
Postow, M.A.
Clinical Advances in Hematology and Oncology H&o 16(5): 353-355
2018
ISSN/ISBN: 1543-0790 PMID: 29851931 Document Number: 694977
Document emailed within 1 workday
Related Documents
Agarwala, S.S.; Kirkwood, J.M. 2002: Update on adjuvant interferon therapy for high-risk melanoma Oncology 16(9): 1177-87; Discussion 1190-2 1197Ariyan, S.; Kirkwood, J.M.; Mitchell, M.S.; Nordlund, J.J.; Lerner, A.B.; Papac, R.J. 1982: Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities Surgery 92(3): 459-463
Chahine, G.; Howayek, M.; Atallah, D. 2009: Adjuvant endocrine therapy in breast cancer. Management of early-risk relapse Le Journal Medical Libanais. Lebanese Medical Journal 57(2): 124-129
Jonasch, E.; Kumar, U.N.; Linette, G.P.; Hodi, F.S.; Soiffer, R.J.; Ryan, B.F.; Sober, A.J.; Mihm, M.C.; Tsao, H.; Langley, R.G.; Cosimi, B.A.; Gadd, M.A.; Tanabe, K.K.; Souba, W.; Haynes, H.A.; Barnhill, R.; Osteen, R.; Haluska, F.G. 2000: Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma Cancer Journal 6(3): 139-145
Overgaard, M. 2000: Evaluation of radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy Rays 25(3): 325-330
Novik, A.V.; Protsenkol, S.A.; Semenova, A.I.; Latipova, D.K.; A S Zhabina; Akhaeva, Z.Y. 2015: Modern methods of molecular targeted therapy for disseminated melanoma Voprosy Onkologii 61(2): 297-302
Stula, N. 1992: Adjuvant cytostatic therapy of breast cancer as an important factor in the postponing of a relapse and longer survival period Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 46(2): 101-111
Schreml, W. 1982: Malignant melanoma - adjuvant systemic therapy Aktuelle Probleme in Chirurgie und Orthopadie 22: 64-65
Eggermont, A.M. 2001: Frontiers in adjuvant therapy in stage II-IIi melanoma Tumori 87(4): S60-S63
McMasters, K.M.; Sober, A.; Kirkwood, J.M. 2003: Sentinel lymph node biopsy and adjuvant therapy for melanoma: evidence revisited Archives of Dermatology 139(1): 99; Author Reply 99-100
Tricarico, M.; Nunziata, C.; Atzori, F.; Concolino, F.; Macchini, V.; D'Atri, S.; Prete, S.P.; Turriziani, M.; Lanzilli, G.; Sera, F.; Abeni, D.; Albanesi, V.; Bonmassar, E.; Pagani, E. 2004: Adjuvant therapy of melanoma patients (stage II, III): a pilot immuno-toxicological study Journal of Experimental and Clinical Cancer Research: Cr 23(4): 573-578
Johnson, D.M.; Hayat, S.Q.; Burton, G.V. 1999: Rheumatoid arthritis complicating adjuvant interferon-alpha therapy for malignant melanoma Journal of Rheumatology 26(4): 1009-1010
Richter, G.; Heidenbluth, I.; Heidelbach, U. 1982: Endolymphatic radionuclide adjuvant therapy of melanoma and its side effects on the cellular immune system Dermatologische Monatschrift 168(12): 797-806
Lee, D.S.; White, D.E.; Hurst, R.; Rosenberg, S.A.; Yang, J.C. 1998: Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy Cancer Journal From Scientific American 4(2): 86-93
Ekelund, B.; Ladefoged, J. 1983: Captopril (Capoten) as a therapeutic adjuvant in the treatment of therapy-resistant hypertension Ugeskrift for Laeger 145(22): 1682-1685
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Morton, D.L. 2004: Immune response to postsurgical adjuvant active immunotherapy with Canvaxin polyvalent cancer vaccine: correlations with clinical course of patients with metastatic melanoma Developments in Biologicals 116: 209
Atashili, J.; Adimora, A.A.; Ndumbe, P.M.; Ikomey, G.M.; Rinas, A.C.; Myers, E.; Eron, J.; Smith, J.S.; Miller, W.C. 2012: High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible? Cancer Epidemiology 36(3): 263-269
Yu, J.; Yu, Y. 2018: Therapeutic effects of targeted nursing interventions combined with auricular-plaster therapy on anxiety level and life quality of Hepatitis B patients Pakistan Journal of Pharmaceutical Sciences 31(4): 1375-1378
Tu, S.-M.; Lin, S.-H.; Podoloff, D.A.; Logothetis, C.J. 2010: Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer Clinical Advances in Hematology and Oncology: H&o 8(5): 341-351